Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism

Cell Transplantation

Volumn 20, Issue 6, 2011, Pages 827-835

  Park, Hyun Jung ^a,b   Bang, Giyoon ^b   Lee, Bo Ra ^b   Kim, Hyun Ok ^b   Lee, Phil Hyu ^b  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Mesenchymal stem cells (MSCs); Multiple system atrophy (MSA); Neuroprotection

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LOCOMOTION; MACROGLIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; WESTERN BLOTTING;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CORPUS STRIATUM; CYTOCHROMES C; DISEASE MODELS, ANIMAL; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MPTP POISONING; MULTIPLE SYSTEM ATROPHY; NEUROTOXINS; NITRO COMPOUNDS; PARKINSONIAN DISORDERS; PROPIONIC ACIDS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SUBSTANTIA NIGRA;

ANIMALIA; MUS;

EID: 80051780265     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X540630     Document Type: Article

References (32)

1. Banisadr G.; Skrzydelski D.; Kitabgi P.; Rostene W.; Parsadaniantz S. M. Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: Constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur. J. Neurosci. 18:1593-1606; 2003.
2. Blandini F.; Cova L.; Armentero M. T.; Zennaro E.; Levandis G.; Bossolasco P.; Calzarossa C.; Mellone M.; Giuseppe B.; Deliliers G. L.; Polli E.; Nappi G.; Silani V. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant. 19:203-217; 2010.
3. Caplan A. I.; Dennis J. E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98:1076-1084; 2006.
4. Chamberlain G.; Fox J.; Ashton B.; Middleton J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749; 2007.
5. Fernagut P. O.; Diguet E.; Bioulac B.; Tison F. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: Reference to striatonigral degeneration. Exp. Neurol. 185:47-62; 2004.
6. Gerhard A.; Banati R. B.; Goerres G. B.; Cagnin A.; Myers R.; Gunn R. N.; Turkheimer F.; Good C. D.; Mathias C. J.; Quinn N.; Schwarz J.; Brooks D. J. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61:686-689; 2003.
7. Hellmann M. A.; Panet H.; Barhum Y.; Melamed E.; Offen D. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci. Lett. 395:124-128; 2006.
8. Ishizawa K.; Komori T.; Sasaki S.; Arai N.; Mizutani T.; Hirose T. Microglial activation parallels system degeneration in multiple system atrophy. J. Neuropathol. Exp. Neurol. 63:43-52; 2004.
9. Karussis D.; Kassis I.; Kurkalli B. G.; Slavin S. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): A proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J. Neurol. Sci. 265:131-135; 2008.
10. Kim H. J.; Lee J. H.; Kim S. H. Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: Secretion of neurotrophic factors and inhibition of apoptosis. J. Neurotrauma 27:131-138; 2010.
11. Kim Y. J.; Park H. J.; Lee G.; Bang O. Y.; Ahn Y. H.; Joe E.; Kim H. O.; Lee P. H. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 57:13-23; 2009.
12. Kirik D.; Rosenblad C.; Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152:259-277; 1998.
13. Krampera M.; Pasini A.; Pizzolo G.; Cosmi L.; Romagnani S.; Annunziato F. Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr. Opin. Pharmacol. 6:435-441; 2006.
14. Lee P. H.; Kim J. W.; Bang O. Y.; Ahn Y. H.; Joo I. S.; Huh K. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin. Pharmacol. Ther. 83:723-730; 2008.
15. Li W. Y.; Choi Y. J.; Lee P. H.; Huh K.; Kang Y. M.; Kim H. S.; Ahn Y. H.; Lee G.; Bang O. Y. Mesenchymal stem cells for ischemic stroke: Changes in effects after ex vivo culturing. Cell Transplant. 17:1045-1059; 2008.
16. Makino S.; Fukuda K.; Miyoshi S.; Konishi F.; Kodama H.; Pan J.; Sano M.; Takahashi T.; Hori S.; Abe H.; Hata J.; Umezawa A.; Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103:697-705; 1999.
17. Matsuura K.; Kabuto H.; Makino H.; Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J. Neurosci. Methods 73:45-48; 1997.
18. Nauta A. J.; Fibbe W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506; 2007.
19. Nee L. E.; Gomez M. R.; Dambrosia J.; Bale S.; Eldridge R.; Polinsky R. J. Environmental-occupational risk factors and familial associations in multiple system atrophy: A preliminary investigation. Clin. Auton. Res. 1:9-13; 1991.
20. Park H. J.; Lee P. H.; Bang O. Y.; Lee G.; Ahn Y. H. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J. Neurochem. 107:141-151; 2008.
21. Pittenger M. F.; Mackay A. M.; Beck S. C.; Jaiswal R. K.; Douglas R.; Mosca J. D.; Moorman M. A.; Simonetti D. W.; Craig S.; Marshak D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
22. Saito A.; Narasimhan P.; Hayashi T.; Okuno S.; Ferrand-Drake M.; Chan P. H. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: Relationships with nerve growth factor. J. Neurosci. 24:1584-1593; 2004.
23. Stefanova N.; Poewe W.; Wenning G. K. Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Exp. Neurol. 210:421-427; 2008.
24. Stefanova N.; Puschban Z.; Fernagut P. O.; Brouillet E.; Tison F.; Reindl M.; Jellinger K. A.; Poewe W.; Wenning G. K. Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: Towards a model of striatonigral degeneration (multiple system atrophy). Acta Neuropathol. 106:157-166; 2003.
25. Stefanova N.; Reindl M.; Neumann M.; Haass C.; Poewe W.; Kahle P. J.; Wenning G. K. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am. J. Pathol. 166:869-876; 2005.
26. Stumm R. K.; Rummel J.; Junker V.; Culmsee C.; Pfeiffer M.; Krieglstein J.; Hollt V.; Schulz S. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: Isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 22:5865-5878; 2002.
27. Ubhi K.; Lee P. H.; Adame A.; Inglis C.; Mante M.; Rockenstein E.; Stefanova N.; Wenning G. K.; Masliah E. Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy. J. Neurosci. Res. 87:2728-2739; 2009.
28. Vanacore N.; Bonifati V.; Fabbrini G.; Colosimo C.; De Michele G.; Marconi R.; Stocchi F.; Nicholl D.; Bonuccelli U.; De Mari M.; Vieregge P.; Meco G. Case-control study of multiple system atrophy. Mov. Disord. 20:158-163; 2005.
29. Wenning G. K.; Colosimo C.; Geser F.; Poewe W. Multiple system atrophy. Lancet Neurol. 3:93-103; 2004.
30. Wenning G. K.; Stefanova N.; Jellinger K. A.; Poewe W.; Schlossmacher M. G. Multiple system atrophy: A primary oligodendrogliopathy. Ann. Neurol. 64:239-246; 2008.
31. West M. J.; Slomianka L.; Gundersen H. J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231:482-497; 1991.
32. Woodbury D.; Schwarz E. J.; Prockop D. J.; Black I. B. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61:364-370; 2000